CLINICAL_TRIALS
trial_result
· 2022-02-02
Clinical Trial Update: ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) [Phase 2]
Summary
Phase 2 trial evaluating ZIMURA in combination with LUCENTIS for neovascular age-related macular degeneration has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ophthotech Corporation | Conditions: Neovascular Age-related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2022-02-02